Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence).
about
The origin and onset of acute venous thrombusComparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-AnalysisEfficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: systematic review and meta-analysis.Is DVT prophylaxis necessary after oncology lower limb surgery? A pilot studyRationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients.Cancer and Venous Thromboembolic Disease: A Review.Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start).Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management.Evidence-based guidance on venous thromboembolism in patients with solid tumoursTherapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics CommitteesPhysician alerts to prevent symptomatic venous thromboembolism in hospitalized patientsComputerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyondRelationship of high CH50 level and interruption of cascade reaction of complement mRNA expression in acute venous thromboembolism patients.Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009)Correlates of in-hospital deaths among hospitalizations with pulmonary embolism: findings from the 2001-2008 National Hospital Discharge SurveyIncreased expressions of integrin subunit β1, β2 and β3 in patients with venous thromboembolism: new markers for venous thromboembolism.Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgeryVenous thromboembolism prophylaxis guideline implementation is improved by nurse directed feedback and audit.Thromboprophylaxis use in medical and surgical inpatients and the impact of an electronic risk assessment tool as part of a multi-factorial intervention. A report on behalf of the elVis study investigatorsSwitching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile.Increased Expressions of Integrin Subunit β1, β2 and β3 in Patients with Acute InfectionProphylaxis of venous thromboembolism in general surgery: guidelines differ and we still need local policies.Bridging therapy for oral anticoagulation increases the risk for bleeding-related complications in total joint arthroplasty.Analysis on the pathogenesis of symptomatic pulmonary embolism with human genomics.Symptomatic venous thromboembolism is a disease related to infection and immune dysfunctionComparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival.Deep Vein Thrombosis in Patients with Severe Motor and Intellectual Disabilities, Especially Diagnosis and Prevention of Recurrence for Chronic Thrombosis-Serial Changes of Sonography and D-Dimer.Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process.Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database.Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer.Outpatient thromboprophylaxis after hip or knee surgery: discrepancies and concernsPerioperative d-dimer levels in patients with musculoskeletal tumorsA novel approach to mechanical prophylaxis: calf impulse technology mimics natural ambulation more effectively than sequential calf compression.Deep vein thrombosis in patients with severe motor and intellectual disabilities.Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations.Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines.Activation of circulated immune cells and inflammatory immune adherence are involved in the whole process of acute venous thrombosis.Early diagnosis of venous thromboembolism as a clinical primary symptom of occult cancer: Core proteins of a venous thrombus.Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism.
P2860
Q26765326-31854843-A3A7-4302-B01A-856E4510BB0FQ26771581-7D3B5AF5-5F04-4F06-B6F9-ADAF4C42F55AQ27690235-C0BAC669-037F-4D97-B9F4-7930E65E6F6BQ28828162-248A7F1A-BE50-476B-82B2-79DEEB88CB7BQ33389637-B81A70AA-A310-4EC0-AFC3-118B7A111653Q33395782-FE50C208-4511-49AA-9DDB-545E2F6AF67EQ33439089-F4BD6988-9DD2-4297-A44A-31758410E6EFQ33722129-C31E0A55-B7E6-4E1E-97E1-3BE28FDCF06CQ33763866-7B72B0B2-264F-4ED1-8080-8EA62539D55AQ33763946-F4947D00-1028-46E6-A8A1-6A0F888B2DAEQ33765274-B182382E-45B9-4CCA-A35B-DE21B5ABC8B3Q33982604-CD587F4E-D972-492B-AA58-E9837C4257FCQ33988196-AE399788-4DE5-4432-BB28-2E959F399704Q34167320-D8F08CCA-D9FC-4635-9C99-7FA476E2FFFDQ34167655-77A58A5A-63E7-4429-80CA-3D4BC4F4FCD9Q34335591-8CC8B2AA-46A7-4A76-983E-475B3EA86A08Q34414964-A56F7A8F-1E4D-4785-85B8-DCCBAB04F363Q34641113-709E0F8F-3774-4B4B-9D65-9FE7FF61E946Q34825362-3B375D2E-9463-4AEE-99B8-57BCE0A41A6EQ35206794-36E44655-0A7E-47A6-8C9E-9F7BB5874BEEQ35904418-A4032FD9-9D81-4C17-A52B-8D038B5BB9A7Q35942125-03C64BC8-DEE7-4DB9-9228-279296F23876Q36002084-36902305-0A92-484B-A932-53FD42FF41C5Q36068886-E2EB882A-BC7C-44ED-94EE-ABA9621C7F52Q36101642-A1A0A6B2-8DDB-495F-89F6-764F7BDB4AB5Q36135083-1630D7AF-ED7F-48B7-B33B-16E2E0213602Q36160668-0DBCC985-7F1C-499E-8012-C80D9C25060FQ36405366-7C7FDA59-11B5-4C7D-BA58-58A15D1FCFC2Q36416906-E1B40511-83CB-4210-B8FE-04B5E120843EQ36599865-E7FCA521-6093-42F2-8598-A4F93DED2D78Q37023306-EC62A121-0855-4B97-B656-8AF54759BA57Q37180032-17AC7922-6675-48FC-B692-D53DB547A9D1Q37203977-33DCB654-1531-47EA-A11E-4A42A2B4BE91Q37310492-AABECC0E-256D-4A05-937E-6FDBC2021F52Q37399707-BBD00963-8AF2-4D77-92D5-DA87C296F47AQ37472172-C1CDA881-88CC-45E8-91D1-A8097D68138BQ37583019-F5050412-491E-4707-BC2C-06FB70706084Q37711443-389C78B2-D85F-4B6B-9604-01BE8725AF8AQ39425994-4C141C84-FB76-41A5-B644-D5F8CD81A484Q42718620-9DCEFA07-4BB2-4EA5-AF75-C5FA514F1024
P2860
Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Prevention and treatment of ve ...... rding to scientific evidence).
@ast
Prevention and treatment of ve ...... rding to scientific evidence).
@en
type
label
Prevention and treatment of ve ...... rding to scientific evidence).
@ast
Prevention and treatment of ve ...... rding to scientific evidence).
@en
prefLabel
Prevention and treatment of ve ...... rding to scientific evidence).
@ast
Prevention and treatment of ve ...... rding to scientific evidence).
@en
P2093
P1476
Prevention and treatment of ve ...... rding to scientific evidence).
@en
P2093
Cardiovascular Disease Educational and Research Trust
Cyprus Cardiovascular Disease Educational and Research Trust
European Venous Forum
International Surgical Thrombosis Forum
International Union of Angiology
Union Internationale de Phlébologie
P304
P577
2006-06-01T00:00:00Z